Caballero, Arth, JR. B.

HRN: 18-00-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFUROXIME 1.5GM (VIAL)
06/08/2022
06/14/2022
IV
1.5gm
Q8
Hypovolemic Shock Sec To Age; T/dengue Fever, T/c Typhoid Fever; T/c Uti; T/c Sol
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: